Cited by 115Gut microbiota and healthProbiotics and Fermented FoodsGastrointestinal motility and disorders

Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers

Open access
Kabbani, Toufic A., Pallav, Kumar, Dowd, Scot E., Villafuerte-Galvez, Javier, Vanga, Rohini R., Castillo, Natalia E., Hansen, Joshua, Dennis, Melinda +2 more·2017·Gut Microbes

Abstract

Probiotics are believed to be beneficial in maintaining a healthy gut microbiota whereas antibiotics are known to induce dysbiosis. This study aimed to examine the effects of the probiotic Saccharomyces boulardii CNCM I-745 (SB), the antibiotic Amoxicillin-Clavulanate (AC) and the combination on the microbiota and symptoms of healthy humans. Healthy subjects were randomized to one of 4 study groups: SB for 14 days, AC for 7 days, SB plus AC, Control (no treatment). Participants gave stool samples and completed gastro-intestinal symptom questionnaires. Microbiota changes in stool specimens were analyzed using 16s rRNA gene pyrosequencing (bTEFAP). Only one subject withdrew prematurely due to adverse events. Subjects treated by S boulardii + AC had fewer adverse events and tolerated the study regimen better than those receiving the AC alone. Control subjects had a stable microbiota throughout the study period. Significant microbiota changes were noted in the AC alone group during antibiotic treatment. AC associated changes included reduced prevalence of the genus Roseburia and increases in Escherichia, Parabacteroides, and Enterobacter. Microbiota alterations reverted toward baseline, but were not yet completely restored 2 weeks after antibiotherapy. No significant shifts in bacterial genera were noted in the SB alone group. Adding SB to AC led to less pronounced microbiota shifts including less overgrowth of Escherichia and to a reduction in antibiotic-associated diarrhea scores. Antibiotic treatment is associated with marked microbiota changes with both reductions and increases in different genera. S. boulardii treatment can mitigate some antibiotic-induced microbiota changes (dysbiosis) and can also reduce antibiotic-associated diarrhea.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19490976.2016.1267890

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Probiotics-treated hosts after antibiotics have a lower number of observed species in gut microbiota.

    “This study and others also demonstrated a lower number of observed species in the gut microbiota of probiotics-treated hosts after antibiotics.93–95”

    From Emerging issues in probiotic safety: 2023 perspectives (2023) · cites this paper as [95]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kabbani, T. A., Pallav, K., Dowd, S. E., Villafuerte-Galvez, J., Vanga, R. R., Castillo, N. E., Hansen, J., Dennis, M., Leffler, D. A., & Kelly, C. P.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • Molecular Research, Shallowater, TX, USA
  • Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA
Corresponding author
Kelly, Ciarán P.
Venue
Gut Microbes
Published
2016-12-14
Volume
8
Issue
1
Pages
17-32
ISSN
  • 1949-0976 (ISSN-L)
  • 1949-0984
OpenAlex
W2561294428
Cited by
115
References
50
Citations by year
2026: 7 · 2025: 11 · 2024: 10 · 2023: 16 · 2022: 19 · 2021: 13 · 2020: 16 · 2019: 11 · 2018: 9 · 2017: 3
FWCI
3.98
Type
journal article
Language
en
Open access
Locations
  • Gut Microbes (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • Harvard Catalyst
  • National Institutes of Health (UL1TR000170)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
Saccharomyces boulardii CNCM I-745, amoxicillin-clavulanic acid, gut microbiota, dysbiosis, probiotics, antibiotics, antibiotic-associated diarrhea, Roseburia, Escherichia, Parabacteroides, Enterobacter, 16S rRNA gene pyrosequencing, healthy volunteers
MeSH terms
Gastrointestinal Microbiome, Saccharomyces boulardii, Adolescent, Adult, Amoxicillin, Anti-Bacterial Agents, Bacteria, Feces, Female, Humans, Male, Middle Aged, Clavulanic Acid, Probiotics, Gastrointestinal Tract, Young Adult, Healthy Volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review